Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.320
-0.100 (-2.92%)
At close: Dec 5, 2025, 4:00 PM EST
3.350
+0.030 (0.90%)
After-hours: Dec 5, 2025, 7:48 PM EST
Rocket Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 359 | 1,312 | 2,702 | 1,481 | 1,407 | 3,322 | |
| Market Cap Growth | -71.15% | -51.45% | 82.43% | 5.29% | -57.65% | 169.40% | |
| Enterprise Value | 162 | 1,102 | 2,290 | 1,197 | 1,008 | 3,162 | |
| Last Close Price | 3.32 | 12.57 | 29.97 | 19.57 | 21.83 | 54.84 | |
| PB Ratio | 1.15 | 2.83 | 5.49 | 3.03 | 3.09 | 6.60 | |
| P/TBV Ratio | 1.44 | 3.29 | 6.31 | 3.49 | 3.32 | 7.03 | |
| Debt / Equity Ratio | 0.08 | 0.06 | 0.05 | 0.05 | 0.05 | 0.12 | |
| Quick Ratio | 7.15 | 9.15 | 7.69 | 9.10 | 17.54 | 14.80 | |
| Current Ratio | 7.30 | 9.30 | 7.80 | 9.30 | 17.69 | 14.94 | |
| Return on Equity (ROE) | -74.88% | -54.14% | -50.01% | -46.98% | -35.29% | -34.46% | |
| Return on Assets (ROA) | -40.56% | -31.21% | -28.69% | -26.68% | -19.10% | -17.43% | |
| Return on Capital (ROIC) | -44.51% | -33.93% | -31.14% | -28.27% | -19.93% | -18.25% | |
| Return on Capital Employed (ROCE) | -73.40% | -56.10% | -49.60% | -43.70% | -35.00% | -24.10% | |
| Earnings Yield | -67.05% | -19.73% | -9.09% | -14.98% | -12.02% | -4.21% | |
| FCF Yield | -56.44% | -16.43% | -7.82% | -12.59% | -9.15% | -2.87% | |
| Buyback Yield / Dilution | -14.70% | -12.85% | -23.27% | -7.77% | -14.18% | -13.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.